Literature DB >> 11093916

Excess portal venous long-chain fatty acids induce syndrome X via HPA axis and sympathetic activation.

L Benthem1, K Keizer, C H Wiegman, J H Strubbe, A B Steffens, F Kuipers, A J Scheurink.   

Abstract

We tested the hypothesis that excessive portal venous supply of long-chain fatty acids to the liver contributes to the development of insulin resistance via activation of the hypothalamus-pituitary-adrenal axis (HPA axis) and sympathetic system. Rats received an intraportal infusion of the long-chain fatty acid oleate (150 nmol/min, 24 h), the medium-chain fatty acid caprylate, or the solvent. Corticosterone (Cort) and norepinephrine (NE) were measured as indexes for HPA axis and sympathetic activity, respectively. Insulin sensitivity was assessed by means of an intravenous glucose tolerance test (IVGTT). Oleate infusion induced increases in plasma Cort (Delta = 13.5 +/- 3.6 microg/dl; P < 0.05) and NE (Delta = 235 +/- 76 ng/l; P < 0.05), whereas caprylate and solvent had no effect. The area under the insulin response curve to the IVGTT was larger in the oleate-treated group than in the caprylate and solvent groups (area = 220 +/- 35 vs. 112 +/- 13 and 106 +/- 8, respectively, P < 0.05). The area under the glucose response curves was comparable [area = 121 +/- 13 (oleate) vs. 135 +/- 20 (caprylate) and 96 +/- 11 (solvent)]. The results are consistent with the concept that increased portal free fatty acid is involved in the induction of visceral obesity-related insulin resistance via activation of the HPA axis and sympathetic system.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11093916     DOI: 10.1152/ajpendo.2000.279.6.E1286

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  18 in total

Review 1.  Abdominal adipose tissue distribution and metabolic risk.

Authors:  Suzy Wong; Ian Janssen; Robert Ross
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

2.  Palatable foods, stress, and energy stores sculpt corticotropin-releasing factor, adrenocorticotropin, and corticosterone concentrations after restraint.

Authors:  Michelle T Foster; James P Warne; Abigail B Ginsberg; Hart F Horneman; Norman C Pecoraro; Susan F Akana; Mary F Dallman
Journal:  Endocrinology       Date:  2008-12-23       Impact factor: 4.736

3.  An afferent vagal nerve pathway links hepatic PPARalpha activation to glucocorticoid-induced insulin resistance and hypertension.

Authors:  Carlos Bernal-Mizrachi; Liu Xiaozhong; Li Yin; Russell H Knutsen; Michael J Howard; Joop J A Arends; Pascual Desantis; Trey Coleman; Clay F Semenkovich
Journal:  Cell Metab       Date:  2007-02       Impact factor: 27.287

Review 4.  Intracellular lipid binding proteins of the small intestine.

Authors:  Luis B Agellon; Matthew J Toth; Alan B R Thomson
Journal:  Mol Cell Biochem       Date:  2002-10       Impact factor: 3.396

5.  Global and Targeted Metabolomics Evidence of the Protective Effect of Chinese Patent Medicine Jinkui Shenqi Pill on Adrenal Insufficiency after Acute Glucocorticoid Withdrawal in Rats.

Authors:  Linjing Zhao; Aihua Zhao; Tianlu Chen; Wenlian Chen; Jiajian Liu; Runmin Wei; Jing Su; Xuelan Tang; Keyi Liu; Ran Zhang; Guoxiang Xie; Jun Panee; Mingfeng Qiu; Wei Jia
Journal:  J Proteome Res       Date:  2016-06-20       Impact factor: 4.466

6.  Chronic exposure to a high-fat diet affects stress axis function differentially in diet-induced obese and diet-resistant rats.

Authors:  A C Shin; S M J MohanKumar; M P Sirivelu; K J Claycombe; J R Haywood; G D Fink; P S MohanKumar
Journal:  Int J Obes (Lond)       Date:  2010-03-09       Impact factor: 5.095

7.  The association among autonomic nervous system function, incident diabetes, and intervention arm in the Diabetes Prevention Program.

Authors:  Mercedes R Carnethon; Ronald J Prineas; Marinella Temprosa; Zhu-Ming Zhang; Gabriel Uwaifo; Mark E Molitch
Journal:  Diabetes Care       Date:  2006-04       Impact factor: 19.112

8.  Differential predictors of insulin resistance in nondiabetic salt-resistant and salt-sensitive subjects.

Authors:  Cheryl L Laffer; Fernando Elijovich
Journal:  Hypertension       Date:  2013-01-02       Impact factor: 10.190

Review 9.  Metabolic syndrome and major depressive disorder: co-occurrence and pathophysiologic overlap.

Authors:  Roger S McIntyre; Natalie L Rasgon; David E Kemp; Ha T Nguyen; Candy W Y Law; Valerie H Taylor; Hanna O Woldeyohannes; Mohammad T Alsuwaidan; Joanna K Soczynska; Byungsu Kim; Maria T Lourenco; Linda S Kahn; Benjamin I Goldstein
Journal:  Curr Diab Rep       Date:  2009-02       Impact factor: 4.810

10.  Vagal afferents contribute to sympathoexcitation-driven metabolic dysfunctions.

Authors:  L Francisco Lorenzo-Martín; Mauricio Menacho-Márquez; Salvatore Fabbiano; Omar Al-Massadi; Antonio Abad; Sonia Rodríguez-Fdez; María A Sevilla; María J Montero; Carlos Diéguez; Rubén Nogueiras; Xosé R Bustelo
Journal:  J Endocrinol       Date:  2019-03-01       Impact factor: 4.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.